Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berlin

Showing results (191-200 of 248) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|January 1, 1985
Synthesis and characterization of selected heteroarotinoids. Pharmacological activity as assessed in vitamin A deficient hamster tracheal organ cultures. Single-crystal X-ray diffraction analysis of 4,4-dimethylthiochroman-6-yl methyl ketone 1,1-dioxide and ethyl (E)-p-[2-(4,4-dimethylthiochroman-6-yl)propenyl]benzoateK M Waugh, K D Berlin, W T Ford, et al.
Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.
Proceedings of the Western Pharmacology Society|January 1, 1992
The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogsM K Pugsley, M J Walker, G L Garrison, et al.
Journal of Medicinal Chemistry|May 1, 1987
Synthesis and antiarrhythmic properties of novel 3-selena-7-azabicyclo[3.3.1]nonanes and derivatives. Single-crystal X-ray diffraction analysis of 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one and 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonane hydroperchlorateM D Thompson, G S Smith, K D Berlin, et al.
Global Spine Journal|April 29, 2017
Carotid Artery Injury in Anterior Cervical Spine Surgery: Multicenter Cohort Study and Literature ReviewRoger Härtl, Marjan Alimi, Mohamed Abdelatif Boukebir, et al.
Oncology|August 25, 2005
A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinomaSherry Morgan-Meadows, Daniel Mulkerin, Jordan D Berlin, et al.
Investigational New Drugs|September 22, 2010
Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabineLaura W Goff, Al B Benson, Patricia M LoRusso, et al.
Journal of Chromatography|December 2, 1992
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineC L Chen, B A Lesseley, C R Clarke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort StudyChengwei Peng, Saad Saffo, Paul E Oberstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinomaMace L Rothenberg, Bonnie LaFleur, Donna E Levy, et al.
Pageof 25

Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|January 1, 1985
Synthesis and characterization of selected heteroarotinoids. Pharmacological activity as assessed in vitamin A deficient hamster tracheal organ cultures. Single-crystal X-ray diffraction analysis of 4,4-dimethylthiochroman-6-yl methyl ketone 1,1-dioxide and ethyl (E)-p-[2-(4,4-dimethylthiochroman-6-yl)propenyl]benzoateK M Waugh, K D Berlin, W T Ford, et al.
Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.
Proceedings of the Western Pharmacology Society|January 1, 1992
The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogsM K Pugsley, M J Walker, G L Garrison, et al.
Journal of Medicinal Chemistry|May 1, 1987
Synthesis and antiarrhythmic properties of novel 3-selena-7-azabicyclo[3.3.1]nonanes and derivatives. Single-crystal X-ray diffraction analysis of 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one and 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonane hydroperchlorateM D Thompson, G S Smith, K D Berlin, et al.
Global Spine Journal|April 29, 2017
Carotid Artery Injury in Anterior Cervical Spine Surgery: Multicenter Cohort Study and Literature ReviewRoger Härtl, Marjan Alimi, Mohamed Abdelatif Boukebir, et al.
Oncology|August 25, 2005
A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinomaSherry Morgan-Meadows, Daniel Mulkerin, Jordan D Berlin, et al.
Investigational New Drugs|September 22, 2010
Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabineLaura W Goff, Al B Benson, Patricia M LoRusso, et al.
Journal of Chromatography|December 2, 1992
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineC L Chen, B A Lesseley, C R Clarke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort StudyChengwei Peng, Saad Saffo, Paul E Oberstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinomaMace L Rothenberg, Bonnie LaFleur, Donna E Levy, et al.
Pageof 25